在癌症的医疗保险优势登记者中,Medigap保护和计划切换
Youngmin Kwon1, Shelley A Jazowski2, Xin Hu3
1Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee.
JAMA health forum
|June 7, 2025
概括
国家Medigap保护允许保证的问题增加了从医疗保险优势转换到癌症患者的传统医疗保险. 这凸显了法规如何帮助受益者更灵活地获得癌症护理.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 卫生政策 卫生政策
- 在瘤学瘤学.
背景情况:
- 越来越多的患有癌症的医疗保险受益人拥有医疗保险优势 (MA) 覆盖.
- MA利用管理可能会限制癌症护理的准入.
- 由于Medigap的入学限制,切换到传统的医疗保险 (TM) 很困难.
研究的目的:
- 检查Medigap保证发行保护是否会影响退出Medicare Advantage的情况.
- 在新诊断的癌症患者中评估Medigap保护和切换到TM之间的关联.
- 了解国家法规如何影响受益人选择癌症护理覆盖范围.
主要方法:
- 对新诊断出癌症的医疗保险受益者 (≥69岁) 的回顾性队列研究 (2014-2019).
- 使用监测,流行病学和最终结果计划相关的医疗保险数据库.
- 差异分析分析比较了MA退学在保证发行状态与其他状态的诊断后.
主要成果:
- 包括180,057名受益者;44.5%的诊断年龄在69-75.5岁之间.
- 在诊断后的保证发行状态中,切换率从2.1%增加到4.7%,而在其他地方则没有变化 (1.8%至1.7%).
- 2.5个百分点的差异差异 (P<.001) 表示切换的相对增加为120%.
结论:
- 国家Medigap保证的发行保护与癌症患者从MA切换到TM的增加有关.
- 这些保护措施有助于受益者过渡,并有可能改善获得癌症护理的机会.
- 转换的差异表明人们在比较和负担计划方面的能力不平等,这需要进一步调查.
更多相关视频
相关概念视频
01:21Cancer Survival Analysis
807
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
807
02:18Cancer
55.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.2K
02:49Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
01:30Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
01:20Comparing the Survival Analysis of Two or More Groups
677
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
677